Phenotypic redifferentiation and cell cluster formation of cultured human articular chondrocytes in a three‐dimensional oriented gelatin scaffold in the presence of PGE 2 ‐ first results of a pilot study
Abstract Modern tissue engineering strategies comprise three elemental parameters: cells, scaffolds and growth factors. Articular cartilage represents a highly specialized tissue which allows frictionless gliding of corresponding articulating surfaces. As the regenerative potential of cartilage is l...
Saved in:
Published in | Journal of biomedical materials research. Part A Vol. 101A; no. 8; pp. 2374 - 2382 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.08.2013
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Modern tissue engineering strategies comprise three elemental parameters: cells, scaffolds and growth factors. Articular cartilage represents a highly specialized tissue which allows frictionless gliding of corresponding articulating surfaces. As the regenerative potential of cartilage is low, tissue engineering‐based strategies for cartilage regeneration represent a huge challenge. Prostaglandins function as regulators in cartilage development and metabolism, especially in growth plate chondrocytes. In this study, it was analyzed if prostaglandin E
2
(PGE
2
) has an effect on the phenotypic differentiation of human chondrocytes cultured in a three‐dimensional (3D) gelatin‐based scaffold made by directional freezing and subsequent freeze‐drying. As a result, it was clearly demonstrated that low doses of PGE
2
revealed beneficial effects on the phenotypic differentiation and collagen II expression of human articular chondrocytes in this 3D cell culture system. In conclusion, PGE
2
is an interesting candidate for tissue engineering applications since it represents an already well‐studied molecule which is available in pharmaceutical quality. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013. |
---|---|
ISSN: | 1549-3296 1552-4965 |
DOI: | 10.1002/jbm.a.34538 |